Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL)
Open Access
- 8 April 2024
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-10
Abstract
Background: Fragile histidine triad (FHIT) has been documented to play a vital role in various cancers including acute lymphoblastic leukemia (ALL). Keeping in view the plausible role of FHIT gene, we aimed to examine DNA promoter hypermethylation and mRNA expression in ALL cases in Kashmir (North India). Methods: A total of 66 cases of ALL were analyzed for FHIT mRNA expression and promoter methylation by qRT-PCR and Methylation Specific-PCR (MS-PCR) respectively. Results: FHIT mRNA expression showed significantly decreased expression in ALL cases with mean fold change of 9.24 ± 5.44 as compared to healthy controls (p = 0.01). The pattern of FHIT deregulation in ALL cases differed significantly between decreased and increased expression (p < 0.0001). A threefold decreased expression was observed in 75% of ALL cases than healthy controls (− 3.58 ± 2.32). ALL patients with FHIT gene promoter hypermethylation presented significantly higher in 80% (53/66) of cases (p = 0.0005). The association of FHIT gene hypermethylation and its subsequent expression showed FHIT mRNA expression as significantly lower in ALL cases with hypermethylation (p = 0.0008). B-ALL cases exhibited a highly significant association between the methylation pattern and its mRNA expression (p = 0.000). In low range WBC group, a significant association was found between increased expression (26%) of the cases and methylated (4%)/unmethylated group 86% (p = 0.0006). Conclusion: The present study conclude that FHIT gene hypermethylation and its altered expression may be linked in the pathogenesis of ALL and provide an evidence for the role of FHIT in the development of ALL.Keywords
Funding Information
- DST, SERB (EMR/2014/001089)
This publication has 48 references indexed in Scilit:
- The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature reviewScientific Reports, 2016
- Reduced FHIT expression is associated with tumor progression in sporadic colon adenocarcinomaExperimental and Molecular Pathology, 2014
- Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031Leukemia, 2014
- Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenarioTumor Biology, 2012
- FHIT: from gene discovery to cancer treatment and preventionThe Lancet Oncology, 2002
- FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: An immunohistochemical and image analysis studyClinical & Experimental Metastasis, 2002
- Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumorsCancer Letters, 2001
- Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemiaOncogene, 1999
- Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cellsBritish Journal of Cancer, 1998
- Decreased or Altered Expression of the FHIT Gene in Human LeukemiasStem Cells, 1997